Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

Summary

The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.

Interventions

• Music intervention · OTHER

  Each GBM study participant in Arm A will receive two 30-minute live synchronous virtual music therapy sessions per week for a period of 8 weeks to be curated by a board-certified music therapist. Arm B participants will receive curated playlists of music created by a music therapist. Participants will then listen to the curated music playlists on the participant's own device twice per week. All participants will complete a total of 16 music therapy sessions, scheduled twice per week over 8 weeks. Each session will last approximately 30 minutes.

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Glioblastoma (Newly Diagnosed)
* Cognitive capacity to respond to surveys
* Access to computer and web access
* Ability to attend virtual music therapy sessions
* Audibly process music
* Proficient in English

Exclusion Criteria:

* Not planning to undergo standard of care radiation therapy and concurrent and adjuvant temozolomide.
* A life expectancy of less than 6 months.
* Concurrent use of any other standard or investigational agents (excepting tumor treating fields).
* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection or psychiatric illness/social situations that would limit adherence with study requirements.

Sites (1)

• Oncology- Broadway, Baltimore, Maryland · RECRUITING